Phage-mediated acquisition of a type III secreted effector protein boosts growth of salmonella by nitrate respiration

mBio

Volumn 3, Issue 3, 2012, Pages

  Lopez, Christopher A ^a   Winter, Sebastian E ^a   Rivera Chávez, Fabian ^a   Xavier, Mariana N ^a   Poon, Victor ^a   Nuccio, Sean Paul ^a   Tsolis, Renée M ^a   Bäumler, Andreas J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; KERATINOCYTE DERIVED CHEMOKINE; NITRIC OXIDE; PROTEIN SOPE; REACTIVE OXYGEN METABOLITE; TETRATHIONIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL OVERGROWTH; BACTERIAL VIRULENCE; BACTERIOPHAGE; COLITIS; CONTROLLED STUDY; ENTERITIS; ENZYME ACTIVITY; GENE FUNCTION; GENE REPRESSION; HORIZONTAL GENE TRANSFER; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; MOUSE; NITRATE METABOLISM; NITRATE RESPIRATION; NONHUMAN; POPULATION ABUNDANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALMONELLA TYPHIMURIUM; SOPE GENE; TYPE III SECRETION SYSTEM;

BOS; SALMONELLA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; SALMONELLA TYPHIMURIUM;

EID: 84863451084     PISSN: None     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00143-12     Document Type: Article

References (48)

1. Anderson ES. 1968. Drug resistance in Salmonella typhimurium and its implications. Br. Med. J. 3:333-339.
2. Rabsch W, Tschäpe H, Bäumler AJ. 2001. Non-typhoidal salmonellosis: emerging problems. Microbes Infect. 3:237-247.
3. Hardt WD, Urlaub H, Galán JE. 1998. A substrate of the centisome 63 type III protein secretion system of Salmonella typhimurium is encoded by a cryptic bacteriophage. Proc. Natl. Acad. Sci. U. S. A. 95:2574-2579.
4. Mirold S, et al. 1999. Isolation of a temperate bacteriophage encoding the type III effector protein SopE from an epidemic Salmonella typhimurium strain. Proc. Natl. Acad. Sci. U. S. A. 96:9845-9850.
5. Ehrbar K, Hardt WD. 2005. Bacteriophage-encoded type III effectors in Salmonella enterica subspecies 1 serovar Typhimurium. Infect. Genet. Evol. 5:1-9.
6. Hardt WD, Chen LM, Schuebel KE, Bustelo XR, Galán JE. 1998. S. typhimurium encodes an activator of Rho GTPases that induces membrane ruffling and nuclear responses in host cells. Cell 93:815-826.
7. Hoffmann C, et al. 2010. In macrophages, caspase-1 activation by SopE and the type III secretion system-1 of S. typhimurium can proceed in the absence of flagellin. PLoS One 5:e12477.
8. Müller AJ, et al. 2009. The S. typhimurium effector SopE induces caspase-1 activation in stromal cells to initiate gut inflammation. Cell Host Microbe 6:125-136.
9. Hapfelmeier S, et al. 2004. Role of the salmonella pathogenicity island 1 effector proteins SipA, SopB, SopE, and SopE2 in Salmonella enterica subspecies 1 serovar Typhimurium colitis in streptomycin-pretreated mice. Infect. Immun. 72:795-809.
10. Zhang S, et al. 2002. Phage mediated horizontal transfer of the sopE1 gene increases enteropathogenicity of Salmonella enterica serotype Typhimurium for calves. FEMS Microbiol. Lett. 217:243-247.
11. Barman M, et al. 2008. Enteric salmonellosis disrupts the microbial ecology of the murine gastrointestinal tract. Infect. Immun. 76:907-915.
12. Stecher B, et al. 2007. Salmonella enterica serovar Typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol. 5:2177-2189.
13. Hoiseth SK, Stocker BA. 1981. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291:238-239.
14. Barthel M, et al. 2003. Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect. Immun. 71:2839-2858.
15. Winter SE, et al. 2010. Gut inflammation provides a respiratory electron acceptor for salmonella. Nature 467:426-429.
16. Szabó C, Ischiropoulos H, Radi R. 2007. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat. Rev. Drug Discov. 6:662-680.
17. Barrett EL, Riggs DL. 1982. Evidence of a second nitrate reductase activity that is distinct from the respiratory enzyme in Salmonella typhimurium. J. Bacteriol. 150:563-571.
18. Kaprálek F. 1972. The physiological role of tetrathionate respiration in growing citrobacter. J. Gen. Microbiol. 71:133-139.
19. Barrett EL, Riggs DL. 1982. Salmonella typhimurium mutants defective in the formate dehydrogenase linked to nitrate reductase. J. Bacteriol. 149: 554-560.
20. Gennis RB, Stewart V. 1996. Respiration, p 217-261. In Neidhardt FC et al. (ed), Escherichia coli and Salmonella: cellular and molecular biology. ASM Press, Washington, DC.
21. McClelland M, et al. 2001. Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 413:852-856.
22. Coburn B, Li Y, Owen D, Vallance BA, Finlay BB. 2005. Salmonella enterica serovar Typhimurium pathogenicity island 2 is necessary for complete virulence in a mouse model of infectious enterocolitis. Infect. Immun. 73:3219-3227.
23. Tsolis RM, Adams LG, Ficht TA, Bäumler AJ. 1999. Contribution of Salmonella typhimurium virulence factors to diarrheal disease in calves. Infect. Immun. 67:4879-4885.
24. Raffatellu M, et al. 2009. Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe 5:476-486.
25. Pelludat C, Mirold S, Hardt WD. 2003. The SopEPhi phage integrates into the ssrA gene of Salmonella enterica serovar Typhimurium A36 and is closely related to the Fels-2 prophage. J. Bacteriol. 185:5182-5191.
26. Wood MW, Rosqvist R, Mullan PB, Edwards MH, Galyov EE. 1996. SopE, a secreted protein of Salmonella dublin, is translocated into the target eukaryotic cell via a sip-dependent mechanism and promotes bacterial entry. Mol. Microbiol. 22:327-338.
27. Mastroeni P, et al. 1999. Interleukin 18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium. Infect. Immun. 67:478-483.
28. Koide M, Kawahara Y, Nakayama I, Tsuda T, Yokoyama M. 1993. Cyclic AMP-elevating agents induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells. Synergism with the induction elicited by inflammatory cytokines. J. Biol. Chem. 268:24959-24966.
29. Koide M, Kawahara Y, Tsuda T, Yokoyama M. 1993. Cytokine-induced expression of an inducible type of nitric oxide synthase gene in cultured vascular smooth muscle cells. FEBS Lett. 318:213-217.
30. Xie QW, Whisnant R, Nathan C. 1993. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J. Exp. Med. 177:1779-1784.
31. Yamada K, Otabe S, Inada C, Takane N, Nonaka K. 1993. Nitric oxide and nitric oxide synthase mRNA induction in mouse islet cells by interferon-gamma plus tumor necrosis factor-alpha. Biochem. Biophys. Res. Commun. 197:22-27.
32. Chiang RC, Cavicchioli R, Gunsalus RP. 1992. Identification and characterization of narQ, a second nitrate sensor for nitrate-dependent gene regulation in Escherichia coli. Mol. Microbiol. 6:1913-1923.
33. Darwin AJ, Li J, Stewart V. 1996. Analysis of nitrate regulatory protein NarL-binding sites in the fdnG and narG operon control regions of Escherichia coli K-12. Mol. Microbiol. 20:621-632.
34. Goh EB, et al. 2005. Hierarchical control of anaerobic gene expression in Escherichia coli K-12: the nitrate-responsive NarX-NarL regulatory system represses synthesis of the fumarate-responsive DcuS-DcuR regulatory system. J. Bacteriol. 187:4890-4899.
35. Li J, Kustu S, Stewart V. 1994. In vitro interaction of nitrate-responsive regulatory protein NarL with DNA target sequences in the fdnG, narG, narK and frdA operon control regions of Escherichia coli K-12. J. Mol. Biol. 241:150-165.
36. Stewart V. 1982. Requirement of Fnr and NarL functions for nitrate reductase expression in Escherichia coli K-12. J. Bacteriol. 151:1320-1325.
37. Stewart V, Berg BL. 1988. Influence of nar (nitrate reductase) genes on nitrate inhibition of formate-hydrogen lyase and fumarate reductase gene expression in Escherichia coli K-12. J. Bacteriol. 170:4437-4444.
38. Stewart V, Parales J, Jr. 1988. Identification and expression of genes narL and narX of the nar (nitrate reductase) locus in Escherichia coli K-12. J. Bacteriol. 170:1589-1597.
39. Thauer RK, Jungermann K, Decker K. 1977. Energy conservation in chemotrophic anaerobic bacteria. Bacteriol. Rev. 41:100-180.
40. Winter SE, Keestra AM, Tsolis RM, Bäumler AJ. 2010. The blessings and curses of intestinal inflammation. Cell Host Microbe 8:36-43.
41. Muller L. 1923. Un nouveau milieu d'enrichissement pour la recherche du Bacille Typhique et Paratyphique. C. R. Seances Soc. Biol. Fil. 89: 434-437.
42. Weingarten RA, Grimes JL, Olson JW. 2008. Role of Campylobacter jejuni respiratory oxidases and reductases in host colonization. Appl. Environ. Microbiol. 74:1367-1375.
43. Clark VL, Campbell LA, Palermo DA, Evans TM, Klimpel KW. 1987. Induction and repression of outer membrane proteins by anaerobic growth of Neisseria gonorrhoeae. Infect. Immun. 55:1359-1364.
44. Palmer KL, Brown SA, Whiteley M. 2007. Membrane-bound nitrate reductase is required for anaerobic growth in cystic fibrosis sputum. J. Bacteriol. 189:4449-4455.
45. Weber I, Fritz C, Ruttkowski S, Kreft A, Bange FC. 2000. Anaerobic nitrate reductase (narGHJI) activity of Mycobacterium bovis BCG in vitro and its contribution to virulence in immunodeficient mice. Mol. Microbiol. 35:1017-1025.
46. Vogel HJ, Bonner DM. 1956. Acetylornithinase of Escherichia coli: partial purification and some properties. J. Biol. Chem. 218:97-106.
47. Price-Carter M, Tingey J, Bobik TA, Roth JR. 2001. The alternative electron acceptor tetrathionate supports B12-dependent anaerobic growth of Salmonella enterica serovar Typhimurium on ethanolamine or 1,2-propanediol. J. Bacteriol. 183:2463-2475.
48. Thiennimitr P, et al. 2011. Intestinal inflammation allows salmonella to use ethanolamine to compete with the microbiota. Proc. Natl. Acad. Sci. U. S. A. 108:17480-17485.